(Q47218200)

English

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

scientific article published in April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

0 references

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

(RS)-sibutramine

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

author name string

Bloom SR

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Frost GS

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Banks LM

4

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Griffiths J

5

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

105-112

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Current estimates of the economic cost of obesity in the United States

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Weight as a risk factor for clinical diabetes in women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Health implications of overweight and obesity in the United States

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Obesity, weight loss and prognosis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Long-term effects of modest weight loss in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Sex differences in weight loss among adults with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Prescription of diabetic diets in the 1980s.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Sibutramine produces dose-related weight loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00071.X

21 January 2018

Identifiers

10.1046/J.1463-1326.2000.00071.X

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/11220522

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47218200&oldid=2146544271"